PLx Pharma Operating Income

PLx Pharma (PLXP) currently reports a operating income of $-40M as of September 2022. That compares with $-24M in the prior-year period — down 69.3% year over year. Use the charts on this page to explore PLx Pharma's operating income history and peer comparisons.

PLx Pharma's operating income decreased from $-24M to $-40M — a 69.3% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PLx Pharma reported $-40M in operating income as of September 2022. That compares with $-24M in the prior-year period — down 69.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-40M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PLx Pharma, and consider following PLXP for alerts when major investors trade the stock.

PLx Pharma is classified in the Healthcare sector. On operating income, it currently shows $-40M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLXP with unrelated industries.